Return to homepagePandemic Pact

The role of angiotensin related medications in COVID-19 risk

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-322

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Prof. Nicholas Harvey

  • Research Location

    United Kingdom

  • Lead Research Institution

    MRC Lifecourse Epidemiology Unit at the University of Southampton

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

A collaboration with UK Biobank and QMUL to investigate role of angiotensin related medications in COVID-19 risk.